CoChat
Sign Up
Cited by 116

The DOI matches its Crossref record, with a small difference in title or year; 3 of the 3 references it cites were found in a registry or an index.

Molecular interactions between apoE and ABCA1

Krimbou, Larbi, Denis, Maxime, Haidar, Bassam, Carrier, Marilyn, Marcil, Michel, Genest, Jacques·2004·Journal of Lipid Research
DOI 10.1194/jlr.m300418-jlr200
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.m300418-jlr200

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Extracellular ApoE, like ApoA1, can induce assembly of cholesterol-laden HDL-like particles via an ABCA1-dependent pathway, and this process is largely unaffected by ApoE polymorphism.

    “Overall, these data support the idea that extracellular ApoE, like ApoA1, can induce the assembly of cholesterol-laden HDL-like particles via an ABCA1-dependent pathway (Krimbou et al., 2004;Wahrle et al., 2004; Figure 2D) and that this process seems largely unaffected by ApoE polymorphism.”

    From Isoform- and cell-state-specific lipidation of ApoE in astrocytes (2022) · cites this paper as Krimbou et al., 2004

  • There were no significant differences in cholesterol efflux between the two isoforms of ApoE (ApoE2 and ApoE4) in BLECs.

    “Interestingly, and as previously reported for brain pericytes [42], neurons [59], fibroblasts [60], and plexus choroid cells [61], there were no significant differences in efflux between the two isoforms of ApoE.”

    From Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier (2015) · cites this paper as [60]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 52

  1. Mahley, 1988, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science., 240, 622, 10.1126/science.3283935 · DOI · Paper page
  2. Poirier, 1995, Apolipoprotein E, synaptic plasticity and Alzheimer's disease, Ann. Med., 27, 663, 10.3109/07853899509019253 · DOI
  3. Zhang, 1992, Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E, Science., 258, 468, 10.1126/science.1411543 · DOI · Paper page
  4. Linton, 1995, Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation, Science., 267, 1034, 10.1126/science.7863332 · DOI · Paper page
  5. Boisvert, 1995, Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation, J. Clin. Invest., 96, 1118, 10.1172/JCI118098 · DOI
  6. Bellosta, 1995, Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice, J. Clin. Invest., 96, 2170, 10.1172/JCI118271 · DOI · Paper page
  7. Weisgraber, 1981, Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms, J. Biol. Chem., 256, 9077, 10.1016/S0021-9258(19)52510-8 · DOI · Paper page
  8. Mahley, 1999, Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes, J. Lipid Res., 40, 1933, 10.1016/S0022-2275(20)32417-2 · DOI · Paper page
  9. Weisgraber, 1996, Human apolipoprotein E: the Alzheimer's disease connection, FASEB J., 10, 1485, 10.1096/fasebj.10.13.8940294 · DOI
  10. Basu, 1982, Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes, J. Biol. Chem., 257, 9788, 10.1016/S0021-9258(18)34141-3 · DOI · Paper page
  11. Hayek, 1994, Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice, Biochem. Biophys. Res. Commun., 205, 1072, 10.1006/bbrc.1994.2775 · DOI
  12. Krimbou, 2003, Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles, J. Lipid Res., 44, 884, 10.1194/jlr.M200273-JLR200 · DOI
  13. Huang, 1995, Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma, J. Clin. Invest., 96, 2693, 10.1172/JCI118336 · DOI · Paper page
  14. Brooks-Wilson, 1999, Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency, Nat. Genet., 22, 336, 10.1038/11905 · DOI · Paper page
  15. Marcil, 1999, Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux, Lancet., 354, 1341, 10.1016/S0140-6736(99)07026-9 · DOI
  16. Brewer, 2003, New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transport, Am. J. Cardiol., 91, 3E, 10.1016/S0002-9149(02)03382-9 · DOI
  17. Attie, 2001, Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis, J. Lipid Res., 42, 1717, 10.1016/S0022-2275(20)31498-X · DOI
  18. Marcil, 2003, Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency, Circulation., 107, 1366, 10.1161/01.CIR.0000056764.53152.F9 · DOI
  19. Gillotte, 1998, Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization, J. Lipid Res., 39, 1918, 10.1016/S0022-2275(20)32490-1 · DOI
  20. Jonas, 1993, The number of amphipathic alpha-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles, J. Biol. Chem., 268, 1596, 10.1016/S0021-9258(18)53895-3 · DOI · Paper page
  21. Denis, 2004, Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1), J. Biol. Chem, 279, 7384, 10.1074/jbc.M306963200 · DOI
  22. Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 · DOI
  23. Wang, 2000, Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1, J. Biol. Chem., 275, 33053, 10.1074/jbc.M005438200 · DOI
  24. Haidar, 2002, cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts, J. Lipid Res., 43, 2087, 10.1194/jlr.M200235-JLR200 · DOI
  25. Krimbou, 1997, Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpE, J. Lipid Res., 38, 35, 10.1016/S0022-2275(20)37273-4 · DOI · Paper page
  26. Krimbou, 2001, Interaction of lecithin:cholesterol acyltransferase (LCAT).alpha 2-macroglobulin complex with low density lipoprotein receptor-related protein (LRP). Evidence for an alpha 2-macroglobulin/LRP receptor-mediated system participating in LCAT clearance, J. Biol. Chem., 276, 33241, 10.1074/jbc.M100326200 · DOI
  27. Denis, 2003, Expression, regulation, and activity of ABCA1 in human cell lines, Mol. Genet. Metab., 78, 265, 10.1016/S1096-7192(03)00020-9 · DOI
  28. Wellington, 2002, Truncation mutations in ABCA1 suppress normal upregulation of full-length ABCA1 by 9-cis-retinoic acid and 22-R-hydroxycholesterol, J. Lipid Res., 43, 1939, 10.1194/jlr.M200277-JLR200 · DOI
  29. Schmitz, 2001, Structure, function and regulation of the ABC1 gene product, Curr. Opin. Lipidol., 12, 129, 10.1097/00041433-200104000-00006 · DOI
  30. Santamarina-Fojo, 2001, Regulation and intracellular trafficking of the ABCA1 transporter, J. Lipid Res., 42, 1339, 10.1016/S0022-2275(20)30266-2 · DOI
  31. Strittmatter, 1994, Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease, Proc. Natl. Acad. Sci. USA., 91, 11183, 10.1073/pnas.91.23.11183 · DOI · Paper page
  32. Schmechel, 1993, Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA., 90, 9649, 10.1073/pnas.90.20.9649 · DOI · Paper page
  33. Krimbou, 1998, Association of apolipoprotein E with alpha2-macroglobulin in human plasma, J. Lipid Res., 39, 2373, 10.1016/S0022-2275(20)33316-2 · DOI · Paper page
  34. von Eckardstein, 2001, High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport, Arterioscler. Thromb. Vasc. Biol., 21, 13, 10.1161/01.ATV.21.1.13 · DOI
  35. Lund-Katz, 2003, High density lipoprotein structure, Front. Biosci., 8, d1044, 10.2741/1077 · DOI
  36. Remaley, 2001, Apolipoprotein specificity for lipid efflux by the human ABCAI transporter, Biochem. Biophys. Res. Commun., 280, 818, 10.1006/bbrc.2000.4219 · DOI
  37. Remaley, 2003, Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway, J. Lipid Res., 44, 828, 10.1194/jlr.M200475-JLR200 · DOI
  38. Chroni, 2003, The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220–231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo, J. Biol. Chem., 278, 6719, 10.1074/jbc.M205232200 · DOI
  39. Panagotopulos, 2002, The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1, J. Biol. Chem., 277, 39477, 10.1074/jbc.M207005200 · DOI
  40. Dong, 1996, Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins, J. Biol. Chem., 271, 19053, 10.1074/jbc.271.32.19053 · DOI · Paper page
  41. Thuahnai, 2003, A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins, J. Lipid Res., 44, 1132, 10.1194/jlr.M200429-JLR200 · DOI
  42. Cullen, 1998, Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages, J. Clin. Invest., 101, 1670, 10.1172/JCI119887 · DOI
  43. Smith, 1996, Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors, J. Biol. Chem., 271, 30647, 10.1074/jbc.271.48.30647 · DOI
  44. Neufeld, 2001, Cellular localization and trafficking of the human ABCA1 transporter, J. Biol. Chem., 276, 27584, 10.1074/jbc.M103264200 · DOI
  45. Gillotte, 1999, Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid, J. Biol. Chem., 274, 2021, 10.1074/jbc.274.4.2021 · DOI
  46. Liu, 2003, Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent HDL particles, J. Biol. Chem., 278, 42976, 10.1074/jbc.M308420200 · DOI
  47. Martinez, 2003, Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I, J. Biol. Chem., 278, 37368, 10.1074/jbc.M307161200 · DOI
  48. Huang, 1994, A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells, Proc. Natl. Acad. Sci. USA., 91, 1834, 10.1073/pnas.91.5.1834 · DOI
  49. Krimbou, 1998, In vitro factors affecting the concentration of gamma-LpE (gamma-LpE) in human plasma, J. Lipid Res., 39, 861, 10.1016/S0022-2275(20)32572-4 · DOI
  50. von Eckardstein, 1995, Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency, Arterioscler. Thromb. Vasc. Biol., 15, 691, 10.1161/01.ATV.15.5.691 · DOI
  51. Haynes, 2000, Efflux of cholesterol from different cellular pools, Biochemistry., 39, 4508, 10.1021/bi992125q · DOI
  52. Gillotte-Taylor, 2002, Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A-I, J. Biol. Chem., 277, 11811, 10.1074/jbc.M108268200 · DOI

Cited by

Sorted by citations

Metadata

Authors
Krimbou, L., Denis, M., Haidar, B., Carrier, M., Marcil, M., & Genest, J.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2004-05
Volume
45
Issue
5
Pages
839-848
ISSN
0022-2275
DOI
10.1194/jlr.m300418-jlr200
Cited by
116
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review